FAP-positive CAFs inhibit T cell infiltration into the tumor through CXCL12, and depletion of these fibroblasts or targeting of CXCL12 increases the sensitivity to immune checkpoint blockade of PC in preclinical models (38). The gene discussed is FAP; the disease is neoplasm.